Lobbying Filing Details

Activity 1

Budget/Appropriations

- Issues related to stroke care

Lobbyists (1)

• LEIF BRIERLEY

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 2

Copyright/Patent/Trademark

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

Lobbyists (3)

• DAVID KAVANAUGH
• WENDY SUSSMAN
• TIMOTHY SWOPE

Government Entities (3)

• SENATE
• HOUSE OF REPRESENTATIVES
• Commerce, Dept of (DOC)

Activity 3

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

Lobbyists (16)

• MRS. JANE MARGARET ADAMS
• DAVID KAVANAUGH
• KELLY WATERS
• LEIF BRIERLEY
• LARRY CAMM
• ABIGAIL PINKELE
• DEANA MCRAE
• AMY PELLEGRINO
• WENDY SUSSMAN
• MRS. MEGHAN DRENAN STONE
• TIMOTHY SWOPE
• COLLEEN VIVALDI
• JULIA KALUSNIAK
• JEFFREY LAST
• FOLASHADE WILSON
• MATTHEW CLARKIN

Government Entities (5)

• SENATE
• HOUSE OF REPRESENTATIVES
• White House Office
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 4

Law Enforcement/Crime/Criminal Justice

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

Lobbyists (2)

• MRS. JANE MARGARET ADAMS
• KELLY WATERS

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 5

Pharmacy

- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.

Lobbyists (2)

• AMY PELLEGRINO
• WENDY SUSSMAN

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 6

Science/Technology

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

Lobbyists (1)

• LEIF BRIERLEY

Government Entities (2)

• SENATE
• HOUSE OF REPRESENTATIVES

Activity 7

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds

Lobbyists (2)

• DAVID KAVANAUGH
• KELLY WATERS

Government Entities (3)

• SENATE
• HOUSE OF REPRESENTATIVES
• Treasury, Dept of

Activity 8

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

Lobbyists (2)

• DAVID KAVANAUGH
• MRS. MEGHAN DRENAN STONE

Government Entities (3)

• SENATE
• HOUSE OF REPRESENTATIVES
• U.S. Trade Representative (USTR)